BUSINESS News 23andMe Lays Off 40% of Staff, Shuts Drug Development Business HS 11/11/2024 Advertisements The genetics company is closing a unit that was once seen as core to its future. Source link Continue Reading Previous Aristocrat to Sell Palarium Mobile Gaming for Up to $820 MillionNext Exxon Says Trump Should Keep U.S. in Paris Climate Pact More Stories BUSINESS News Volkswagen Workers Begin Striking as Labor Dispute Escalates HS 02/12/2024 BUSINESS News Intel CEO Pat Gelsinger Resigns After Struggling to Turn Around Chip Maker HS 02/12/2024 BUSINESS News Jammed Thanksgiving Flights Push U.S. Air Travel to Record HS 02/12/2024